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Mucosal innate lymphoid cell (ILC) subsets promote
immune responses to pathogens by producing
distinct signature cytokines in response to changes
in the cytokine microenvironment. We previously
identified human ILC3 distinguished by interleukin-
22 (IL-22) secretion. Here we characterized a human
ILC1 subset that produced interferon-g (IFN-g) in
response to IL-12 and IL-15 and had a unique integrin
profile, intraepithelial location, hallmarks of TGF-b
imprinting, and a memory-activated phenotype.
Because tissue-resident memory CD8+ T cells share
this profile, intraepithelial ILC1 may be their innate
counterparts. In mice, intraepithelial ILC1 were dis-
tinguished by CD160 expression and required Nfil3-
and Tbx21-encoded transcription factors for devel-
opment, but not IL-15 receptor-a, indicating that
intraepithelial ILC1 are distinct from conventional NK
cells. Intraepithelial ILC1 were amplified in Crohn’s
disease patients and contributed to pathology in
the anti-CD40-induced colitis model in mice. Thus,
intraepithelial ILC1 may initiate IFN-g responses
against pathogens but contribute to pathology
when dysregulated.
INTRODUCTION
Recent studies have shown that both aggregated and diffuse
lymphoid tissues of the oral and gastrointestinal mucosa harbor
various innate lymphoid cell (ILC) subsets that contribute to early
immune responses against pathogens by secreting different
cytokines (Cherrier et al., 2012; Guo et al., 2012; Spits et al.,
2013). Remarkably, these ILC subsets resemble the discrete
T helper cell effectors Th1, Th2, Th17, and Th22 cells in terms
of the signature cytokines and transcription factors that deter-
mine their development. We recently identified a unique type of
human ILCmarked by the natural killer (NK) cell surfacemolecule
NKp44, the signature cytokine interleukin-22 (IL-22), expressionof the receptors for IL-1 (IL-1R), IL-7 (IL-7Ra), and IL-23
(IL-23Ra), and the chemokine receptor CCR6 (Cella et al.,
2009, 2010). We refer to these cells and their murine counter-
parts as type 3 ILC (ILC3) (Spits et al., 2013). Acting on epithelial
cells, IL-22 induces the release of antimicrobial peptides that
protect the integrity of the mucosal barrier from pathogens
(Ouyang et al., 2011; Sonnenberg et al., 2011). IL-22 release is
triggered by IL-23 and enhanced by IL-1, both of which are
produced by antigen presenting cells (APC) in response to path-
ogens or other inflammatory stimuli. ILC3 development requires
IL-7 signaling and the transcription factors Id2, RORgt (Cherrier
et al., 2012; Spits et al., 2013), AHR (Kiss et al., 2011; Lee et al.,
2012; Qiu et al., 2012), and Notch (Lee et al., 2012; Possot et al.,
2011). Human ILC3 maintain a certain degree of functional plas-
ticity, because they can produce interferon-g (IFN-g) when
cultured in vitro with IL-7+IL-2, IL-1b+IL-2, or IL-7+IL-1b+IL-23
(Cella et al., 2010).
Additional cells expressing NKp44 or other NK cell markers
have been described in the human oral and gastrointestinal
mucosa, including tonsilar NKp44+CD103+ NK cells (Cella
et al., 2010), small intestine CD7+CD3 intraepithelial lympho-
cytes (Eiras et al., 2000), colon lamina propria NKp46+NKp44
cells (Takayama et al., 2010), and rectal intraepithelial and lamina
propria NKp46+ cells (Sips et al., 2012). Cells with NK cell activity
were also reported in the murine intestinal epithelium and lamina
propria (Carman et al., 1986; Tagliabue et al., 1982). Although
these reports suggest further phenotypic and functional hetero-
geneity of mucosal ILC, the functions and responsiveness to
pathogenic stimuli of these ILC subsets are poorly understood.
It is also unclear whether these cells are related to ILC3 or
classical NK cells. In this study, we demonstrated that the human
tonsil and intestinal mucosa contain a unique NKp44+CD103+
cell subset that produced IFN-g in response to IL-12 and
IL-15. These cells were different from classical NK cells in that
they were selectively located within the epithelium, expressed
the chemokine receptor CXCR6, and reflected features of
TGF-b imprinting. Moreover, they had an integrin profile and a
memory-activated phenotype similar to that previously observed
in tissue resident memory CD8 T (Trm) cells, which are virus-
specific cells that persist in the mucosae and skin after the
resolution of viral infections (Casey et al., 2012; Gebhardt
et al., 2009; Jiang et al., 2012; Sathaliyawala et al., 2013; WakimImmunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc. 769
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Figure 1. Mucosal NKp44+CD103+ andNKp44–CD103– Cells Specialize in IFN-gProduction in Response to IL-12 and IL-15, SeeAlso Figure S1
CD56+ cells were enriched from tonsils and analyzed for their surface markers and functions.
(legend continued on next page)
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Type 1 Innate Lymphoid Cells in the Gutet al., 2012, reviewed in Cauley and Lefranc¸ois, 2013). Intraepi-
thelial NKp44+CD103+ cell numbers were increased in Crohn’s
disease patients, suggesting that they contribute to inflam-
matory bowel disease (IBD).
We further identified the murine counterparts of intraepithelial
NKp44+CD103+ cells, whichwere distinguished by expression of
CD160, as well as NKp46 and NK1.1. We found that these cells
were strongly reduced in mice lacking the transcription factors
Nfil3 (also known as E4bp4) (Male et al., 2012) and Tbx21, but
not in Il15ra/ mice, corroborating that intraepithelial NKp46+
NK1.1+CD160+ cells represent an ILC1 subset distinct from clas-
sical NK cells. Murine intraepithelial ILC1 promptly produced
IFN-g in the anti-CD40-induced colitis model and contributed
to intestinal inflammation. Thus, intraepithelial ILC1may facilitate
immune responses during exposure to infections but contribute
to IBD when dysregulated.
RESULTS
Human Mucosal-Associated Lymphoid Tissues
Comprise Diverse ILC Subsets
We sought to delineate the diversity of human ILC in mucosal-
associated lymphoid tissues. We isolated CD56+ cells from
human tonsils and analyzed them by flow cytometry for the ex-
pression of NKp44, CD103, and CD3. Within the CD3 compart-
ment, we identified two cell subsets, NKp44+ and NKp44 cells
(Figure 1A). NKp44+ cells could be further divided into CD103+
and CD103 cells. The NKp44 population was mainly CD103
but included small numbers of CD103lo cells, which varied
considerably among individuals and therefore were not further
examined.
We next determined which of these subsets produced IL-22.
CD56+ cells isolated from tonsils were stimulated with IL-23
and analyzed for intracellular content of IL-22 as well as surface
expression of NKp44, CD103, and the prototypic ILC3 cell
surface markers, including CCR6, IL-1R, and IL-7Ra. NKp44+
CD103 cells produced IL-22 (Figure 1A) and many expressed
CCR6, IL-1R, and IL-7Ra (Figure 1B) and therefore corre-
sponded to ILC3. In contrast, NKp44+CD103+ cells and NKp44
CD103 cells produced no or little IL-22 (Figure 1A) and did not
express CCR6, IL-1R, or IL-7Ra (Figure 1B).
Mucosal NKp44+CD103+ and NKp44–CD103– Cells Are
Type 1 ILC
To evaluate the function of NKp44+CD103+ and NKp44CD103
cells, we initially assessed cytokine production by intracellular
staining following stimulation with PMA and ionomycin. Both
NKp44+CD103+ and NKp44CD103 cells produced more
IFN-g and CCL4 than ILC3, but less GM-CSF (Figure 1C). We
then asked which physiological stimuli induce IFN-g in NKp44+(A) Left shows expression of NKp44 and CD103 on tonsil CD56+ cells, gated on li
IL-23 and stained for intracellular IL-22. Cells were gated on the NKp44+ and the
(B) Surface markers of tonsilar NKp44+CD103+ cells (red lines), ILC3 (NKp44+CD
(C) After stimulation in vitrowith PMA and ionomycin, cytokine content of tonsil CD
cytokine-positive cells within NKp44+CD103+ cells, ILC3, and NKp44CD103 c
(D) Tonsil and peripheral blood CD56+ cells were cultured with IL-12, IL-15, IL-18,
tonsil NKp44CD103 cells, blood CD56lo (CD3CD16+CD56lo), and blood CD5
(E) Cytotoxic potential of NKp44+ cells was analyzed by intracellular staining for gra
NKp44+CD103+ cells.
(F) Frequency of CD107a+ cells following coculture of ILC subsets with K562. S
represented as mean ± SD.CD103+ and NKp44CD103 cells. Typically, ILCs produce
signature cytokines when challenged with other cytokines, in-
dependent of signaling through immunoreceptors (Guo et al.,
2012; Soudja et al., 2012). Accordingly, both NKp44+CD103+
and NKp44CD103 cells produced IFN-g when stimulated
in vitro with IL-12 or IL-15 (Figure 1D). Moreover, IL-12 and
IL-15 had a strong synergistic effect. IL-23, which stimulates
ILC3, was ineffective (data not shown). IFN-g production by
NKp44CD103 cells was particularly efficient in a subset ex-
pressing CD27 (see Figure S1 available online), similar to what
has been shown for blood NK cells (Silva et al., 2008).
Interestingly, the magnitude of IFN-g production by NKp44+
CD103+ and NKp44CD103 cells was similar to that of periph-
eral blood CD56hi NK cells (Figure 1D), which are known
producers of IFN-g in response to cytokines (Cooper et al.,
2001), and superior to that of peripheral blood CD56lo NK cells
(Figure 1D), which specialize in the release of lytic granules
(Cooper et al., 2001). However, although CD56hi NK cells were
responsive to IL-18, NKp44+CD103+ and NKp44CD103 cells
produced equal amounts of IFN-g following stimulation with
either IL-12+IL-18 or IL-12 alone, demonstrating that these cells
do not respond to IL-18 (Figure 1D). Based on their ability to
rapidly produce IFN-g in response to IL-12 and IL-15, we
conclude that NKp44+CD103+ cells and NKp44CD103 cells
belong to type 1 ILC (ILC1), which are the innate counterparts
of Th1 CD4 T cells and include blood NK cells, particularly the
CD56hi subset.
NKp44+CD103+ and NKp44CD103 ILC1 not only produced
IFN-g but approximately 50% of these cells also contained intra-
cellular perforin and granzymes (Figure 1E; data not shown),
consistent with potential cytotoxic activity. In NKp44CD103
ILC1, granzyme production precisely paralleled IFN-g produc-
tion (Figure S1). To corroborate the lytic activity of NKp44+
CD103+ and NKp44CD103 ILC1, we monitored degranulation
of all ILC subsets by measuring cell surface expression of
CD107a in the presence of the tumor cell line K562. Both
NKp44+CD103+ and NKp44CD103 ILC1 expressed more
CD107a than ILC3 (Figure 1F).We conclude that NKp44+CD103+
and NKp44CD103 ILC1 not only produce IFN-g but can also
release lytic mediators when activating receptors are engaged
by cognate ligands expressed on target cells.
NKp44+CD103+ ILC1 Have an Intraepithelial Location
CD103 promotes the interaction of lymphocytes with epithelial
cells by binding E-cadherin (Cepek et al., 1994) and is a marker
of intraepithelial T lymphocytes (Cheroutre et al., 2011; Sheridan
and Lefranc¸ois, 2010). The majority of NKp44+CD103+ ILC1 ex-
pressed additional intraepithelial lymphocyte markers, such as
CD160, which has been recently shown to bind to HVEM on
epithelial cells promoting epithelial cell defense mechanismsve CD3CD19 cells. Right shows that tonsil CD56+ cells were stimulated with
NKp44 fractions.
103, blue lines), and NKp44CD103 cells (black lines).
56+ cells was analyzed by flow cytometry. Data displayed are the frequencies of
ells obtained from 5 to 13 different donors.
or with combinations of these cytokines. After 9 hr, tonsil NKp44+CD103+ cells,
6hi (CD3CD16CD56hi) cells were analyzed for IFN-g content.
nzymes and perforin. Gray profiles indicate the ILC3 subset; black lines denote
hown are combined results obtained from seven individual donors. Data are
Immunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc. 771
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Figure 2. Expression of Adhesion Molecules,
Markers of TGF-b Imprinting, and Activation in
NKp44+CD103+ ILC1, See Also Figure S2
(A–D) CD56+ cells enriched from tonsils were analyzed
for surface markers gating on live CD3CD19 cells.
Red lines indicate NKp44+CD103+ ILC1, blue lines
denote ILC3 (NKp44+CD103), and black lines indicate
NKp44CD103 cells. Representative data from ex-
periments with three or more individual tonsil samples
are shown.
(E) Tonsil CD56+ cells were sorted into the three
subsets described in (A)–(D), and mRNA content for
NEDD9 and ITGAE (encoding CD103) was analyzed by
qRT-PCR. Displayed are normalized data from qRT-
PCR experiments with three (NEDD9) and five (ITGAE)
individual donors. Data are represented as mean ± SD.
(F) NKp44+CD103+ cells were sorted from tonsils,
cultured in IL-15 with or without the addition of TGF-b
for 9 days, and analyzed for CD103 and NKp44
expression.
(G) Tonsil CD56+ cells were analyzed for surface
expression of activation markers as in (A)–(D).
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as EWI-101) (Allez et al., 2002) (Figure 2A). Neither ILC3 nor
NKp44CD103 ILC1 expressed substantial amounts of
CD160 or CD101. Thus, we hypothesized that NKp44+CD103+
ILC1 are intraepithelial. We investigated serial sections of human
tonsils for NKp44 and CD103 expression by immunohistochem-
istry. We found that numerous NKp44+ cells localized in the
epithelia overlaying the crypts and the surface of the tonsil,772 Immunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc.particularly in ‘‘lymphoepithelial’’ areas where
lymphocytes infiltrate the epithelium (Fig-
ure S2). Fewer NKp44+ cells were found in
the interfollicular areas, and none in the
follicles (Figure S2; data not shown). CD103
was found on a fraction of NKp44+ cells,
and two-color staining with CD103 and CD3
confirmed the presence of CD103+ cells in
tonsil epithelia that were CD3 and thus
distinct from T cells (Figure S2). We conclude
that the large majority of NKp44+CD103+
ILC1 have an intraepithelial location.
Intraepithelial ILC1 Have the Integrin
Profile of CD8 Trm Cells
We asked whether CD103 is part of a unique
integrin profile that distinguishes NKp44+
CD103+ ILC1 from other ILC subsets within
tonsils. We found that NKp44+CD103+ ILC1
selectively express high amounts of beta7
integrin, which associates with CD103 to
form aEb7 heterodimers (Figure 2B). Con-
versely, NKp44+CD103+ ILC1 expressed low
amounts of CD11b (alpha M integrin) and
CD11c (alpha X integrin). Additionally,
NKp44+CD103+ ILC1 expressed high levels
of the collagen-binding integrin CD49a (also
known as alpha 1 integrin or VLA-1) (Fig-
ure 2B). Notably, expression of aEb7 andCD49a is characteristic of CD8 Trm, which are also preferentially
located within the epithelium and poised for prompt effector
functions (Cauley and Lefranc¸ois, 2013). In contrast to NKp44+
CD103+ ILC1, NKp44CD103 ILC1 and ILC3 expressed the
integrins CD11b and CD11c and lacked aEb7 and CD49a.
We also assessed the chemokine receptor profile of NKp44+
CD103+ ILC1. Unexpectedly, NKp44+CD103+ ILC1 did not
express CCR9, which has been shown to be a major chemokine
Figure 3. NKp44+CD103+ Cells Express T-bet, Eomes, and Aiolos
(A) Tonsil CD56+ cells were stained for intracellular T-bet, RORgt, Helios, and Foxp3. Dark gray profiles indicate ILC3, black lines represent NKp44+CD103+ ILC1,
and dotted lines indicate NKp44CD103 cells. Light gray profiles indicate staining with isotype-matched control antibody. Representative data from three
individual tonsil samples are shown.
(B) Tonsil CD56+ cells were sorted into the three subsets described in (A), andmRNA content forAHR, IKZF3 (encoding Aiolos) and EOMESwas analyzed by qRT-
PCR. Displayed are normalized data from four (AHR), nine (IKZF3), and five (EOMES) donors. Data are represented as mean ± SD.
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In contrast, they expressed CXCR6, a chemokine receptor that
was previously found on liver NK cells with memory-like features
(Paust et al., 2010) and that mediates lymphoepithelial adhesion
in the gut (Hase et al., 2006). Thus, intraepithelial ILC1 express
a unique repertoire of homing receptors that promote retention
in the epithelia.
Intraepithelial ILC1 Bear Hallmarks of TGF-b Imprinting
and Activation
It has been shown that CD103 denotes a cellular response to
TGF-b (Keskin et al., 2007). Indeed, NKp44+CD103+ ILC1 ex-
pressed additional markers of TGF-b exposure including the
tetraspanin CD9 (Keskin et al., 2007) and the integrin-signaling
molecule NEDD9 (Giampieri et al., 2009) (Figures 2D and 2E).
Corroborating the influence of TGF-b in NKp44+CD103+ ILC1
development, we found that tonsil NKp44+CD103+ cells cultured
in vitro with TGF-b together with either IL-2 or IL-15 maintained
CD103 expression, whereas in the presence of IL-2 and IL-15
alone cells survived and proliferated but lost CD103 expression
over time (Figure 2F). By regulating the expression of integrins
and integrin signaling molecules, TGF-b may promote adhesion
of ILC1 to epithelial cells (Giampieri et al., 2009). Interestingly,
blood NK cells only engender few NKp44+CD103+ ILC1 cells
when cultured with either IL-2 or IL-15 and TGF-b or supernatant
from intestinal epithelial cell lines (data not shown), suggesting
that, although related to conventional NK cells, NKp44+CD103+
ILC1 cells may have a unique developmental pathway.
Intraepithelial NKp44+CD103+ ILC1 expressed higher
amounts of the IL-2 receptor subunit beta (IL-2Rb or CD122),as well as the activation markers CD39, CD69, and SIRP-g,
than did NKp44CD103 ILC1 (Figure 2G). NK cell receptors,
such as NKp46, NKp30, CD244, CD94, NKG2A, NKG2C,
and NKG2D, were similar in NKp44+CD103+ ILC1 and
NKp44CD103 ILC1 (Figure S2). KIR expression was very
low on both cell subsets as it was on ILC3 (Figure S2). CD57,
which was previously noted on rectal mucosa intraepithelial
NK cells (Sips et al., 2012), was not observed on any subset
(Figure S2). Considering the entire phenotypic analysis of
ILC subsets, we conclude that intraepithelial ILC1 express
hallmarks of TGF-b imprinting and activation. The expression
of activation markers on intraepithelial ILC1 is reminiscent
of the activated phenotype seen on CD8 Trm (Cauley and
Lefranc¸ois, 2013).
NKp44+CD103+ ILC1 Express T-bet and Eomes
To gain insight into the development of intraepithelial ILC1,
we compared all ILC subsets for expression of transcription
factors that play a key role in ILC development by intracellular
staining and RT-PCR. Both NKp44+CD103+ and NKp44
CD103 ILC1 expressed T-bet and Eomes (Figure 3A and 3B),
which have been implicated in the development and function
of conventional NK cells (Gordon et al., 2012), but not RORgt
or AHR, which drive ILC3 cell differentiation (Spits et al., 2013).
Foxp3 was undetectable in all subsets. Interestingly, NKp44+
CD103+ ILC1 expressed higher levels of IKZF3 transcript than
other ILC. IKZF3 encodes Aiolos, a member of the Ikaros family
of transcription factors that regulates B and T cell development
(Cortes et al., 1999) but heretofore has not been implicated in
ILC development or function.Immunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc. 773
Figure 4. Activation of NKp44+CD103+ Cells
by Coculture with Epithelial Cells and
Myeloid Cells Stimulated with TLR Agonists
(A and B) Tonsil CD56+ cells were cocultured for
9 hr with the colon carcinoma cell line Colo-205
that was pretreated with poly I:C or Pam3CSK4.
IFN-g content of NKp44+CD103+ ILC1 was
determined by intracellular staining. (A) shows
staining from one representative experiment. (B)
shows compiled data from four experiments,
showing the percentage of IFN-g+ cells within the
NKp44+CD103+ ILC1.
(C and D) Tonsil NKp44+CD103+ cells were FACS
sorted and cocultured for 48 hr with Colo-205 cells
that were left unstimulated or treated with
Pam3CSK4. IFN-g levels in culture supernatants
were determined by CBA. (C) shows representa-
tive results from one experiment. (D) shows
summary of experiments with three donors,
showing IFN-g levels produced by NKp44+
CD103+ cells of individual donors.
(E and F) Tonsil CD56+ cells were cocultured for
9 hr with peripheral blood CD14+ monocytes (E) or
monocyte-derived dendritic cells (F) pretreated
with poly I:C or Pam3CSK4. IFN-g content of
NKp44+CD103+ cells was determined by intra-
cellular staining.
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Signals
Because NKp44+CD103+ ILC1 are intraepithelial, they may
produce IFN-g in response to signals produced by epithelial
cells. To test this hypothesis, we challenged an epithelial cell
line with different TLR agonists. We then added CD56+ cells
isolated from human tonsils to the cultures and analyzed intra-
cellular IFN-g content in NKp44+CD103+ ILC1 by flow cytometry.
NKp44+CD103+ ILC1 produced more IFN-g when incubated
with epithelial cells stimulated with the TLR2 agonist Pam3CSK4
than with epithelial cells stimulated with the TLR3 agonist
polyI:C or unstimulated epithelial cells (Figures 4A and 4B).
Similarly, elevated IFN-g levels were detected in the superna-
tants from FACS-sorted NKp44+CD103+ ILC1 cocultured with
Pam3CSK4-stimulated epithelial cells (Figures 4C and 4D).774 Immunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc.TLR2 agonists had no direct effect on
ILC1 (data not shown). These results
demonstrate that intraepithelial ILC1 are
responsive to danger signals produced
by epithelial cells.
Because IL-12 induces IFN-g produc-
tion by intraepithelial ILC1 (see Figure 1)
and is secreted by inflammatory mono-
cytes, macrophages, and dendritic cells
(DCs) (Trinchieri, 2003), we asked
whether NKp44+CD103+ ILC1 produce
IFN-g in response to signals generated
by monocytes and monocyte-derived
DC. We challenged monocytes and
monocyte-derived DC with different TLR
agonists. We then added CD56+ cells
isolated from human tonsils to thecultures and analyzed the IFN-g content in ILC1 by flow
cytometry. ILC1 produced more IFN-g when incubated with
polyI:C-stimulated monocytes and DC than with Pam3CSK4-
stimulated monocytes and DC (Figures 4E and 4F). Altogether
these results indicate that intraepithelial ILC1 respond to danger
signals originating from both epithelial cells and myeloid cells. It
is likely that epithelial cells transmit the dominant danger signals
when pathogenic attack is limited to the mucosal surface,
whereas monocytes and DC stimulation of intraepithelial
ILC1 might prevail when the epithelial barrier is breached,
leading to DC activation in the underlying tissue.
Intraepithelial ILC1 Expand during Crohn’s Disease
We sought to extend our analysis of NKp44+CD103+ ILC1 to the
intestinal mucosa. We separated intraepithelial lymphocytes
Figure 5. NKp44+CD103+ ILC1 in Normal and CD Intestinal Mucosa, See Also Figure S3
(A and B) Intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) of human small intestine (A) and colon (B) were stained for CD103 and several
ILC1 markers. Cells were gated on live CD45+CD3 lymphocytes. Shown are representative data from two to three different individuals.
(C) Serial frozen sections from human appendix were stained for NKp44 (brown, left panel), CD103 (brown, middle panel), and CD3 (brown, right panel). Cells
expressing both NKp44 and CD103 within the surface epithelium (SE) are indicated (arrows). Sections are counterstained with hematoxylin.
(D) Fixed sections from human appendix (left) and small intestinal villi (right) were stained for CD3 (blue) and T-bet (brown). T-bet+CD3 are indicated (arrows).
(E) Samples from ileal resections of CD patients (CD) and non-IBD controls (NC) were analyzed for the ratio of NKp44+CD103+ cells versus CD3+ T cells within
CD45+ IEL.
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areas of human small intestine specimens that had been surgi-
cally removed to treat IBD. NKp44+CD103+ ILC1 were found
primarily in the IEL and only in low numbers within LPL,
corroborating our hypothesis that NKp44+CD103+ ILC1 are
mainly intraepithelial lymphocytes (Figure 5A). In contrast, ILC3
were mainly found in the lamina propria. NKp44+CD103+ ILC1
from the small intestine expressed most prototypic markers
noted on their tonsilar counterparts, including NKp44, NKp46,
CD39 (Figure 5A), CD101, CD49a, and CD160 (data not shown).
The only exception was CD94, which was poorly expressed on
small intestine NKp44+CD103+ ILC1 (Figure 5A). NKp44+CD103+ILC1 were also present in the epithelium of the colon (Figure 5B)
but were not detected in nonmucosal tissues, such as axillary
lymph nodes (Figure S3) or peripheral blood (data not shown).
These results confirmed that NKp44+CD103+ ILC1 are selec-
tively located within the mucosal epithelium.
Immunohistochemical analysis of NKp44, CD103, and CD3 in
the appendix and intestinal villi showed that although the
majority of NKp44+ cells are found in the lamina propria, some
cells are located within the epithelium (Figure 5C; data not
shown). Among numerous CD103+ cells detectable within the
epithelium, some were CD3, indicating that the intestinal
epithelium harbors a small but detectable subset of NKp44+Immunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc. 775
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Type 1 Innate Lymphoid Cells in the GutCD103+ ILC1 among numerous intraepithelial T cells. Immuno-
histochemical analysis of T-bet and CD3 distribution in appendix
and intestinal villi confirmed the presence in the intestinal epithe-
lium of a small but detectable number of CD3T-bet+ ILC amid
numerous CD3+T-bet+ T cells (Figure 5D).
During IBD, dysregulated T cell production of IFN-g and IL-17
causes excessive inflammation, tissue damage, and loss of
barrier function (Geremia et al., 2011; Strober and Fuss, 2011).
Because of their ability to secrete IFN-g and CCL4, intraepithelial
NKp44+CD103+ ILC1 might contribute to the pathogenesis of
IBD if inappropriately activated. We compared the frequencies
of these cells in samples of small intestine surgically excised
from Crohn’s disease (CD) patients and non-IBD controls.
Remarkably, we detected higher frequencies of NKp44+CD103+
ILC1 within the intraepithelial lymphocytes in CD patients
compared to non-IBD controls (Figure 5E). Although low cell
yields from these small tissue samples prevented functional
studies, their increase during inflammation suggested that
NKp44+CD103+ ILC1 are involved in the pathogenesis of CD.
Murine ILC1 Are Largely Independent of IL-15
Receptor a
We sought to identify the murine counterpart of intraepithelial
NKp44+CD103+ ILC1. To facilitate their recognition, we isolated
IEL from Rag1/ mice. NKp44 is only encoded in humans, and
CD103 was unexpectedly inadequate because CD103+ cells
were hardly detectable within CD3 IEL (data not shown). In
contrast, CD160 was an optimal marker of intraepithelial ILC1
because we detected a distinct population of CD160+NKp46+
NK1.1+ cells within the IEL of Rag1/ mice (Figure 6A). Spleen
NK cells did not express CD160 in steady state, corroborating
the specificity of this marker for intraepithelial ILC1 (Figure S4).
Stimulation of IEL of Rag1/ and C57BL/6 mice with IL-12
and IL-15 induced rapid IFN-g production by CD3CD160+
NKp46+NK1.1+ cells, mirroring the human ILC1 response
(Figures 6B and 6C). In contrast, IL-23 did not induce IFN-g
production (Figure 6C). The identification of the phenotype of
murine intraepithelial ILC1 gave us the opportunity to investigate
the transcription factors required for their development. Intraepi-
thelial ILC1 were conserved in Rorc/ and Ahr/ mice, which
lack ILC3 (Figure 6D). In contrast, these cells were dramatically
reduced in the IEL of mice with knock-out mutations of Nfil3 or
Tbx21, which encode two transcription factors previously shown
to be master regulators of NK cell development (Gordon et al.,
2012; Male et al., 2012) (Figure 6D). Normal numbers of ILC1
were present in the IEL of germ-free mice and slightly reduced
numbers of ILC1 were found in neonatal mice (Figure 6E).
Altogether, these results indicated that intraepithelial ILC1 can
develop independently of the intestinal microbiota and are
more related to the NK cell lineage than to ILC3.
To gain more insights into the developmental relationship
between intraepithelial ILC1 and conventional NK cells, we
analyzed these cells in Il15ra/ mice. As previously reported
(Lodolce et al., 1998), these mice showed an almost complete
absence of splenic NK cells (Figure 6F). However, intraepithelial
ILC1 were minimally affected by lack of IL-15 receptor
a (IL-15Ra) (Figure 6F) and maintained expression of CD160
(Figure 6G). These data corroborate that intraepithelial ILC1 are
a unique ILC1 subset distinct from conventional NK cells.776 Immunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc.Intraepithelial ILC1 Contribute to Inflammation
in a Model of Colitis
Because the numbers of intraepithelial ILC1 are increased in CD
and may have proinflammatory functions, we evaluated the
presence and function of intraepithelial ILC1 in a mouse model
of IBD caused by injection of anti-CD40 inRag1/mice (Buono-
core et al., 2010; Uhlig et al., 2006). Following injection of
anti-CD40, Rag1/ mice rapidly lost weight and developed
colitis as previously described (Uhlig et al., 2006). Analysis of
IEL isolated from the small intestine 36 hr after injection of anti-
CD40 revealed a robust production of IFN-g by CD160+NKp46+
NK1.1+ cells (Figure 7A), corroborating their early proinflamma-
tory function in this model. IFN-g was also produced by a small
percentage of NKp46+NK1.1 cells, which correspond to ILC3
(Spits et al., 2013). This observation was consistent with our
previous demonstration that human ILC3 are functionally plastic.
ILC3 can produce IFN-g when cultured in vitro with IL-7+IL-2,
IL-1b+IL-2, or IL-7+IL-1b+IL-23, acquire responsiveness to
IL-12, upregulate the expression of T-bet, and downregulate
that of RORgt (Cella et al., 2010; Figure S5). In vivo, the functional
conversion of ILC3 into IFN-g-producing cells may occur when
there is increased production of IL-15, IL-23, or IL-2 due to
excessive activation of APC or T cells in IBD.
To determine whether CD160+NKp46+NK1.1+ ILC1 directly
contribute to the pathogenesis of anti-CD40-induced colitis in
Rag1/mice, we depleted intraepithelial ILC1 and conventional
NK cells with anti-NK1.1. Anti-NK1.1 treatment did not affect
weight loss over a 7 day time period (Figure 7B), suggesting that
depletion of ILC1 or NK cells does not affect the systemic wast-
ing disease. However, histochemical analysis of tissue sections
of proximal colon revealed significantly less cellular inflammatory
infiltrates and epithelial damage in NK1.1 depleted than control
mice (Figure 7C). These results suggest that intraepithelial ILC1
may play a pathogenic role in IBD through IFN-g secretion.
DISCUSSION
Our study extends the diversity of human ILC within the oral and
gastrointestinal mucosa, characterizing a subset of human
IFN-g-producing ILC, designated intraepithelial ILC1. Although
related to NK cells, intraepithelial ILC1 were unique in that they
were located in the mucosal epithelium, shared multiple pheno-
typic and functional features with CD8 Trm, and had several
hallmarks of TGF-b imprinting. We also identified the murine in-
traepithelial ILC1 and found that they were largely independent
of IL-15Ra, corroborating that these ILCs are distinct from
conventional NK cells, which require IL-15Ra for development.
Although sharing the NKp44 marker with human ILC3, ILC1
also clearly differed from ILC3 in terms of phenotype, function,
and transcription factors involved in development. In addition
to intraepithelial ILC1, we also identified a subset of human
IFN-g-producing NKp44CD103 ILC1 that may be related to
intraepithelial ILC1 and perhaps can acquire similar character-
istics when transiting from the lamina propria to the epithelium.
ILC produce signature cytokines in response to cytokine
stimulation (Guo et al., 2012). Optimal production requires stim-
ulation by a STAT activator and an NF-kB inducer, most com-
monly an IL-1 family member. For example, IFN-g-producing
NK cells respond to the IL-1 family member IL-18 and the
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Figure 6. Phenotype, Function, and Developmental Requirements of Murine Intraepithelial ILC1, See Also Figure S4
(A) Small intestine IEL ofRag-1/mice were analyzed for the expression of NKp46, NK1.1, and CD160. Themajority of NKp46+NK1.1+ IEL (histogram, black line)
express CD160, whereas NKp46+NK1.1 ILC3 (histogram, gray profile) do not. Control staining of NKp46+NK1.1+ cells is indicated by a dotted line. Cells in the
dot plots were gated on live lymphocytes.
(B) IEL from Rag-1/ mice were stimulated in vitro with IL-12 and IL-15 and analyzed for intracellular IFN-g. Cells were gated on CD45+NK1.1+ cells.
(C) IEL from C57BL/6 mice were stimulated in vitro with a combination of IL-12 and IL-15, or with IL-23 and IL-1b, and analyzed for intracellular IFN-g. Cells were
gated on CD45+CD3NKp46+ cells.
(D) Frequencies of intraepithelial ILC1 in the small intestine of Nfil3/, Ahr/, Tbx21/, and Rorc/ mice and littermate controls. Cells were gated on
CD45+CD3CD19.
(E) Small intestinal IEL of conventionally housed (SPF) or germ-free C57BL/6 mice, as well as of adult and neonate C57BL/6 mice, were analyzed for the presence
of NKp46+NK1.1+ cells. Cells were gated on CD45+CD3CD19.
(F) ILC1 within IEL are largely preserved in Il15ra/ mice. Left shows frequencies of NKp46+NK1.1+ cells within spleen and intestinal IEL (gated on CD45+
CD3CD19) fromwild-type and IL15ra/mice from experiments with four mice each. Data are represented asmean ± SD. Right shows representative dot plots
from IEL from wild-type and IL15ra/ mice.
(G) ILC1 from small intestinal epithelium of wild-type (black line) and IL15ra/ mice (dotted line) express similar levels of CD160. Cells were gated on CD45+
CD3CD19, followed by gating on NKp46+NK1.1+ cells. The gray profile indicates CD160 on wild-type splenic NKp46+NK1.1+ cells.
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Figure 7. Intraepithelial ILC1 Produce IFN-g and Contribute to Pathology during anti-CD40-Induced Colitis, See Also Figure S5
(A) Rag-1/mice were left untreated or injected with anti-CD40 to induce colitis. Thirty-six hr after injection, small intestinal IEL were isolated, and the frequency
of IFN-g-positive cells within ILC1 (top panel) and ILC3 (bottom panel), gated as shown in Figure 6A, was determined by intracellular staining.
(B and C) ILC1 contribute to the intestinal pathology during anti-CD40-induced colitis. Rag-1/ mice were treated with anti-NK1.1 to deplete intraepithelial
ILC1, and colitiswas inducedwith anti-CD40. Intestinal tissue pathology in the proximal colonwas analyzedon day 7 after anti-CD40 treatment. ‘‘Control’’ indicates
mice injectedwithanti-CD40withoutanti-NK1.1 treatment. (B) shows theweightofmice recordedas thepercentageof initialweight.Dataare representedasmean±
SD (C) Left shows H&E staining of proximal colon sections at day 7 after anti-CD40 injection, showing more severe cellular infiltration in control mice compared
to anti-NK1.1-treated mice. Right shows colitis score at day 7 determined from H&E staining of proximal colon samples. Data are represented as mean ± SD.
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conventional NK cells because they required a STAT4 (IL-12)
and a STAT5 (IL-15) activator, whereas the NF-kB activator
IL-18 was not effective alone or in combination with IL-12 or
IL-15. Given that IL-15 has been shown to be an important
inflammatory mediator in gastrointestinal diseases such as
celiac disease (Jabri and Sollid, 2009), the responsiveness of
intraepithelial ILC1 to IL-15 may be an important pathogenic
factor in intestinal inflammation.
Interestingly, intraepithelial ILC1 shared multiple phenotypic
and functional features with CD8 Trm, which persist in the
gastrointestinal tract, lungmucosae, and skin long after a primary
infection has cleared and are very effective at preventing
reinfection (Cauley and Lefranc¸ois, 2013). Given this, we envision
that intraepithelial ILC1 are the innate counterparts of nonmigra-
tory CD8 Trm. Epstein-Barr virus (Strowig et al., 2008) and human
cytomegalovirus infection of tonsils as well as viral infections of
the small intestine (Carman et al., 1986) may result in an accumu-
lation or activation of intraepithelial ILC1, which are retained in
the epithelium to prevent reinfection. It will be important to778 Immunity 38, 769–781, April 18, 2013 ª2013 Elsevier Inc.explore the relationship between intraepithelial ILC1 and the
recently reported memory NK cells (Cooper et al., 2009; Romee
et al., 2012; Sun and Lanier, 2011). Like intraepithelial CD8
T cells, ILC1 also expressed CD160 and therefore may be the
major innate trigger of HVEM-mediated epithelial antimicrobial
response (Shui et al., 2012).
Intraepithelial ILC1 were unique in that they were located in
the mucosal epithelium and showed several hallmarks of
TGF-b imprinting, particularly expression of CD103, CD9, and
NEDD9, most likely reflecting close interaction with the epithe-
lium that produces TGF-b. TGF-b imprinting was previously
observed in decidual NK cells, which are in close contact with
the fetal trophoblast and presumably contribute to maternal-
fetal tolerance (Koopman et al., 2003). However, in contrast to
decidual NK cells, intraepithelial ILC1 had an activated-memory
phenotype and secreted IFN-g as well as lytic mediators, consis-
tent with a proinflammatory function. By inducing a unique profile
of adhesion and integrin signaling molecules, TGF-b may be
important for maintaining the adhesiveness of ILC1 to epithelial
cells rather than inducing a tolerogenic function.
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thelial ILC1 as CD3 IEL that coexpress CD160, NKp46, and
NK1.1. This observation enabled us to examine the develop-
mental pathway of intraepithelial ILC1 in mice with targeted
mutations of master transcription factors, demonstrating the
requirement of Nfil3 and Tbx21, factors involved in the develop-
ment of conventional NK cells. In contrast, Rorc and Ahr
were dispensable. Although these results, together with the
abundance of T-bet protein and EOMES transcript in human
intraepithelial ILC1, suggested a relationship of intraepithelial
ILC1 with conventional NK cells, we found that intraepithelial
ILC1 were largely independent of IL-15Ra, indicating that intrae-
pithelial ILC1 are developmentally distinct from conventional
NK cells. It is possible that intraepithelial ILC1 are capable of
exploiting other cytokines for their development, such as IL-7
or IL-2, or they do not require transpresentation of IL-15.
Moreover, ILC1 expressed the transcription factor Aiolos, which
may contribute to some of the unique developmental and
phenotypic features of these cells.
We found that frequencies of intraepithelial ILC1 were
increased in Crohn’s disease patients. We also observed that
intraepithelial ILC1 produced high amounts of IFN-g in Rag1/
mice treated with anti-CD40, a model of colitis characterized by
wasting syndrome and severe intestinal inflammation. Although
it was previously shown that IL-12 and IL-23 play a major role
in the wasting syndrome and colon inflammation, respectively
(Buonocore et al., 2010; Uhlig et al., 2006), we found that deple-
tion of intraepithelial ILC1 ameliorated proximal colon inflam-
mation. Together, these results indicate that intraepithelial ILC1
are poised for robust IFN-g production, which may be important
for orchestrating innate responses to infectious agents and pre-
venting reinfection after elimination of the inciting pathogen.
However, they may contribute to IBD when dysregulated.
EXPERIMENTAL PROCEDURES
Antibodies and Flow Cytometry
The commercial sources of the antibodies used for flow cytometric analysis
are indicated in Supplemental Experimental Procedures. Stained cells were
analyzed on a FACS Calibur or FACS Canto using CellQuest and Diva
programs, respectively. Dead cells were excluded with propidium iodide
(Sigma Aldrich) or 7-AAD (BD Biosciences). Anti-CD45 was included in flow
cytometric analysis of small intestinal lymphocytes to gate on live CD45+
cells. Flow cytometric analyses were performed using the FlowJo software
(Tree Star).
Mice
All mice were maintained in a pathogen-free facility and animal protocols were
approved by the Washington University School of Medicine (WUSM) animal
studies committee. Ahr/ mice were described before (Lee et al., 2012).
Rorc/andRag-1/micewere obtained from Jackson laboratories.Nfil3/,
Tbx21/, Il15ra/, and germ-free adult female mice were kindly provided by
Drs Paul Rothman (University of Iowa), Takeshi Egawa (WUSM), Anthony R.
French (WUSM), and Jeffrey I. Gordon (WUSM), respectively. All mice were
on a C57BL/6 background. Mice were used between 6 and 8 weeks of age,
with the exception of those used to study neonate IEL from the small intestine,
which were 10 days old.
Tissues and Cell Isolation
Tonsils, intestinal samples, and peripheral blood products were obtained
under the approval of the WUSM institutional review board. Tissue sources
are described in Supplemental Experimental Procedures. Tonsilar lymphocytesuspensions and peripheral blood mononuclear cells (PBMC) were prepared
as previously described (Cella et al., 2009; Cella et al., 2010). IEL and LPL
were prepared as previously described (Lefrancois and Lycke, 2001). CD56+
cells were enriched from tonsil lymphocytes by magnetic cell sorting using
CD56MicroBeads (Miltenyi Biotec). ILC subsets were sorted from CD56+ cells
as previously reported (Cella et al., 2010) and described in Supplemental
Experimental Procedures.
ILC Culture for Analysis of Cytokines and Degranulation
For cytokine analyses, CD56-enriched tonsil cells were stimulated with 107 M
PMA and 1 mg/ml ionomycin (both from Sigma Aldrich) for 6 hr at 37C. 2 mM
monensin (Sigma Aldrich) was added during the final 4 hr of culture. Alterna-
tively, human tonsil CD56+ cells or mouse IEL were cultured for 9 hr in the
presence of 50 ng/ml human IL-15 and 10 ng/ml human or mouse IL-12, or
with 100 ng/ml human or mouse IL-23 (all from Peprotech). Cells were stained
for surface markers, followed by fixation, intracellular cytokine staining and
analysis by flow cytometry. IFN-g content in supernatants of CD56+ cells
cultured with epithelial cells was measured by Cytometric Bead Array (CBA)
(BD Biosciences). For degranulation assays, CD56+ cells were cocultured
with K562 tumor cells in the presence of anti-CD107a for 5 hr. Cocultures
are described in detail in Supplemental Experimental Procedures.
Tissue Immunohistochemistry and Immunofluorescence
Immunohistochemistry and immunofluorescence staining of frozen or paraffin-
embedded tissues are described in Supplemental Experimental Procedures.
qRT-PCR
RNA and cDNA were prepared from sorted ILC as previously described
(Cella et al., 2009). Quantitative PCR was performed using SYBRGreen
(BIORAD). Results were normalized to the housekeeping gene GAPDH
and displayed as (mRNA [gene of interest] per mRNA [GAPDH]) 3 106, using
the following formula: 2-[Ct (gene of interest) – Ct (GAPDH)] 3 106. Primers are listed
in Supplemental Experimental Procedures.
Anti-CD40-Induced Colitis Model
Rag-1/ mice were injected intraperitoneally (i.p.) with 50 ml of anti-CD40
ascites (kind gift of Dr. Antonius Rolink, University of Basel). To deplete
ILC1, we injected mice i.p. with 200 ml anti-NK1.1 ascites (PK136) at
days2 and 0 of anti-CD40 treatment. Mice were weighed daily and sacrificed
at day 7 after anti-CD40 injection to analyze intestinal pathology as previously
described (Uhlig et al., 2006). To evaluate IFN-g production by IEL, mice were
sacrificed 36 hr after anti-CD40 injection. Small intestinal IEL were cultured
for 4 hr in the presence of monensin and then analyzed for intracellular
IFN-g content.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2013.02.010.
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